Failure of pyridoxine to reduce drug-induced dyskinesias
Related Experiment Videos
Abstract:
The use of pyridoxine seems to be ineffective in reducing tardive dyskinesia.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The psychopathology and measurement of environmental stress.
Community mental health journal·2013
The prolactin response to flutroline hydrochloride in schizophrenic patients.
Journal of clinical pharmacology·1983
Schizophrenia and dialysis.
Artificial organs·1983
The therapeutic efficacy of hemodialysis in schizophrenia.
The New England journal of medicine·1983
Flutroline in the treatment of the schizophrenic patient.
Journal of clinical pharmacology·1982
A comparison of dopamine receptor blocking assay with plasma drug levels of haloperidol in schizophrenic patients.
Journal of clinical pharmacology·1981
PABPN1 pathogenic expansion in the UK Biobank: reframing genetic prevalence of oculopharyngeal muscular dystrophy.
Journal of neurology, neurosurgery, and psychiatry·2026
Air pollution and the risk of multiple sclerosis relapses in the Paris region, the CONFISEP study.
Journal of neurology, neurosurgery, and psychiatry·2026
Stroke recurrence after primary intracerebral haemorrhage: a population-based study of clinical and MRI factors associated with recurrence.
Journal of neurology, neurosurgery, and psychiatry·2026
Comparative effectiveness of inebilizumab versus conventional immunotherapies in AQP4-IgG-positive NMOSD: a prospective cohort study with time-varying treatment effects.
Journal of neurology, neurosurgery, and psychiatry·2026
Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.
Journal of neurology, neurosurgery, and psychiatry·2026
MRI activity in pre-symptomatic multiple sclerosis: the role of paramagnetic rim lesions beyond the 2024 McDonald diagnostic criteria.
Journal of neurology, neurosurgery, and psychiatry·2026
The LAI-Oral Antipsychotic Efficacy-Effectiveness Paradox in Schizophrenia.
Medicina (Kaunas, Lithuania)·2026
The phosphodiesterase 4B inhibitor A33 blocks locomotor stimulation by low doses of ethanol and diazepam.
The Journal of pharmacology and experimental therapeutics·2026